Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation

Improvements in survival have been achieved for children and adolescents with acute myeloid leukemia (AML), with the 5-year survival rates increasing from less than 20% to more than 70%.[1] However...